
- Home
- Products & Services
ProfitGuard
Group purchasing and wholesaler contract negotiation service with business intelligence tools.
BuyLineA no-contract online pharmaceutical ordering service with competitive pricing and loyalty rewards points.
- About
- Elements
- News
- Resources
- Contact
Torrent Pharmaceuticals Expands Losartan Recall
September 24, 2019
Torrent Pharmaceutical has issued a voluntary nationwide recall of Losartan, a drug used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in patients with Type 2 diabetes. Testing revealed trace amounts of an unexpected impurity of N-Methylnitrosobutyric acid in three lots of Losartan Potassium Tablets USP and two lots of Losartan Potassium/Hydrochlorothiazide Tablets USP.
Patients currently taking Losartan are recommended to continue taking the medication and to consult their doctor or pharmacist for advice on alternative treatment.
Read more about the recall on the FDA website.
Related
Archive
- 2019
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2017
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2016
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2015
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2014
- December
- November
- October
- September
- August
- March
- February
- 2013
- July
- June
- May
- April
- 2012
- December
- June
- April
- March
- February
- 2011
- December
- November
- August
- July
© 2019 PBA Health. All rights reserved.
MENU